Table 2 Frequency of polytherapy during clozapine treatment
From: Factors predicting serum clozapine levels in Middle Eastern patients: an observational study
Drug class | Frequency (% of total sample) |
|---|---|
Concomitant use of drugs for depression and anxiety | 38 (40.4) |
 Fluoxetine | 9 (9.6) |
 Escitalopram | 9 (9.6) |
 Fluvoxamine | 4 (4.3) |
 Sertraline | 2 (2.1) |
 Paroxetine | 2 (2.1) |
 Venlafaxine | 3 (3.2) |
 Imipramine | 1 (1.1) |
 Clomipramine | 1 (1.1) |
 Amitriptyline | 2 (2.1) |
 Mirtazapine | 5 (5.3) |
Concomitant use of anticonvulsants or lithium | 25 (25.6) |
 Valproate | 11 (11.7) |
 Lamotrigine | 3 (3.2) |
 Lithium | 9 (9.6) |
 Lithium and valproate | 1 (1.1) |
Concomitant use of other drugs for psychosis | 14 (14.9) |
 Amisulpride | 3 (3.2) |
 Aripiprazole | 9 (9.6) |
 Quetiapine | 1 (1.1) |
 Risperidone | 1 (1.1) |